Grant: Project Grant
University of Alberta
$807,075.00
Brain cell volume reduction in animal models and people with intracerebral hemorrhagic stroke.
EF 2020-21
Résumé
An intracerebral hemorrhage (ICH) is a devastating stroke caused by a bleed into the brain. Almost 40% of ICH patients die, many in days. The bleed destroys brain tissue, alters the delicate balance of important ions and water, and takes up valuable space within the skull. This causes pressure to rise. High intracranial pressure (ICP) impairs blood flow to the brain, causing more damage and sometimes death. The body has several natural ways to compensate and help lower ICP. Our animal research has found an additional mechanism. We discovered that cell shrinkage (CS) occurs in areas located away from the damaged tissue. Some cell bodies shrink by up to 50%. This means that those parts of the brain become a bit smaller. This frees up space within the skull and limits the rise in ICP. While this helps reduce the risk of death, it still commonly occurs after very large ICHs. Thus, we need to do more to treat high ICP. Our research will study patients who died from a large ICH. Using their brain tissue, we will look for whether CS occurs in humans, if there are any harmful effects, and we will examine how CS occurs. Concurrently, we will use rat models of severe ICH to determine how age, hypertension and ICP control therapies affect CS in male and female rats. These are clinically important factors that we will incorporate into our research to improve the validity of our animal studies (e.g., to explain the negative impact of hypertension). We will also look to better document how CS affects neuronal health and function. Finally, we will examine rat and human tissue to determine the mechanisms underlying CS. For example, we know that movement of potassium, chloride and water across a cell membrane is very important to cell size, and so we will study these and other mechanisms. Eventually, we hope to safely manipulate CS to improve the medical management of high ICP after large strokes and other brain injuries, thereby improving survival and recovery.
Programme
Project Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
433380
Name
Colbourne Frederick
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Systems & Circuits Neurosciences - A
Projecttitle
Brain cell volume reduction in animal models and people with intracerebral hemorrhagic stroke.
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$807,075
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cell Volume Regulation; Hematoma; Intracerebral Hemorrhage; Intracranial Pressure; Mass Effect; Neurodegeneration; Patient; Rat; Stroke; Treatment
Abstract
An intracerebral hemorrhage (ICH) is a devastating stroke caused by a bleed into the brain. Almost 40% of ICH patients die, many in days. The bleed destroys brain tissue, alters the delicate balance of important ions and water, and takes up valuable space within the skull. This causes pressure to rise. High intracranial pressure (ICP) impairs blood flow to the brain, causing more damage and sometimes death. The body has several natural ways to compensate and help lower ICP. Our animal research has found an additional mechanism. We discovered that cell shrinkage (CS) occurs in areas located away from the damaged tissue. Some cell bodies shrink by up to 50%. This means that those parts of the brain become a bit smaller. This frees up space within the skull and limits the rise in ICP. While this helps reduce the risk of death, it still commonly occurs after very large ICHs. Thus, we need to do more to treat high ICP. Our research will study patients who died from a large ICH. Using their brain tissue, we will look for whether CS occurs in humans, if there are any harmful effects, and we will examine how CS occurs. Concurrently, we will use rat models of severe ICH to determine how age, hypertension and ICP control therapies affect CS in male and female rats. These are clinically important factors that we will incorporate into our research to improve the validity of our animal studies (e.g., to explain the negative impact of hypertension). We will also look to better document how CS affects neuronal health and function. Finally, we will examine rat and human tissue to determine the mechanisms underlying CS. For example, we know that movement of potassium, chloride and water across a cell membrane is very important to cell size, and so we will study these and other mechanisms. Eventually, we hope to safely manipulate CS to improve the medical management of high ICP after large strokes and other brain injuries, thereby improving survival and recovery.
Competitiondate
202010
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Colbourne, Frederick
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $807,075~ $0~